Alpha Cognition Inc Total Liabilities
Alpha Cognition Inc total liabilities. Based on the latest financial reports, Alpha Cognition Inc (ACOG) has total liabilities worth $12.39 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Alpha Cognition Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Alpha Cognition Inc (2020–2024)
Total liabilities of Alpha Cognition Inc from 2020 to 2024. This chart illustrates how Alpha Cognition Inc's total liabilities have evolved over time, based on quarterly financial data.
Alpha Cognition Inc Competitors by Total Liabilities
The table below lists competitors of Alpha Cognition Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
LG Corp Preferred
KO:003555
|
Korea | ₩3.06 Trillion |
|
Sound Point Meridian Capital, Inc.
NYSE:SPMC
|
USA | $175.83 Million |
|
De Licacy Industrial Co Ltd
TW:1464
|
Taiwan | NT$11.72 Billion |
|
Valiant Organics Limited
NSE:VALIANTORG
|
India | Rs4.71 Billion |
|
Eagle Cold Storage Enterprise Co Ltd
TWO:8905
|
Taiwan | NT$750.47 Million |
|
Energy World Corporation Ltd
AU:EWC
|
Australia | AU$480.12 Million |
|
Global Dividend Growth Split Corp Class A
TO:GDV
|
Canada | CA$167.00 Million |
|
Dekpol SA
WAR:DEK
|
Poland | zł1.25 Billion |
Liability Composition Analysis (2020–2024)
This chart breaks down Alpha Cognition Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Alpha Cognition Inc balance sheet assets.
Liquidity & Leverage Metrics
Alpha Cognition Inc Total Liabilities Ratios Explained
Alpha Cognition Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.69 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Alpha Cognition Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Alpha Cognition Inc (2020–2024)
The table below shows the annual total liabilities of Alpha Cognition Inc from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $9.27 Million | +29.44% |
| 2023-12-31 | $7.16 Million | +67.75% |
| 2022-12-31 | $4.27 Million | +10.92% |
| 2021-12-31 | $3.85 Million | -54.27% |
| 2020-12-31 | $8.42 Million | -- |
About Alpha Cognition Inc
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatm… Read more